BofA expects Medtronic’s pipeline development to see it continue to surpass organic growth expectations as in the previous four quarters.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

While M&A fueled the company's expansion in a rapidly growing and changing market, Global struggled to integrate some of ...

CEO Phil Kardis highlighted 2024 as a year of reversals, noting a 100 basis point increase in 10-year Treasury yields despite Fed rate cuts. He emphasized the acquisition of Palisades Group as a ...

Bond yields, though down from their highs, are still at attractive levels compared to the last 10 years, in our view. Read ...

Those seeking generation AI investing strategies and tools and back-testing. However, you must have at least a Prime membership ($14.99 monthly) to access the AI-powered financial advisor and ...

Our research team assigns Neutral ratings to strategies they’re not confident ... Typically, these stocks fit into one of four investment themes: mass affluence, new technology, restructuring ...

You can hear investors screaming about how overvalued Palantir (PLTR) stock is after this week’s earnings report. Heck, investors were telling the same story a year ago, but the stock is still ...

The company’s operating EBITDA stood at ₹127 Crore, up by 5.30% y-o-y, over ₹120.60 Crore in the previous corresponding period.